1. Home
  2. NL vs TKNO Comparison

NL vs TKNO Comparison

Compare NL & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NL Industries Inc.

NL

NL Industries Inc.

HOLD

Current Price

$5.50

Market Cap

283.9M

Sector

Industrials

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$4.58

Market Cap

236.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NL
TKNO
Founded
1891
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.9M
236.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NL
TKNO
Price
$5.50
$4.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.0K
202.3K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
10.38%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$159,004,000.00
$39,801,000.00
Revenue This Year
$15.75
$9.52
Revenue Next Year
$2.44
$15.20
P/E Ratio
$28.47
N/A
Revenue Growth
5.52
9.50
52 Week Low
$5.04
$3.94
52 Week High
$9.42
$10.37

Technical Indicators

Market Signals
Indicator
NL
TKNO
Relative Strength Index (RSI) 48.70 44.14
Support Level $5.04 $4.50
Resistance Level $5.75 $4.81
Average True Range (ATR) 0.26 0.29
MACD 0.03 0.04
Stochastic Oscillator 76.31 50.65

Price Performance

Historical Comparison
NL
TKNO

About NL NL Industries Inc.

NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: